Biodesix
Biodesix is a leading diagnostic solutions company dedicated to transforming patient care and improving outcomes through personalized diagnostics. They provide advanced diagnostic tests and custom development services, supporting clinical decisions to expedite personalized care for lung disease patients. Their mission is to conquer patient diseases with personalized diagnostics, and their vision is to transform standard of care through innovative testing and research. The company emphasizes a culture of impact, excellence, and teamwork, and has received numerous recognitions including Top Workplaces and industry awards. Biodesix operates highly accredited laboratories and a manufacturing facility, with a focus on molecular and proteomic technologies, clinical studies, and diagnostic development. They serve biopharmaceutical, life sciences, and research institutions, and are committed to making their tests accessible through comprehensive billing and reimbursement programs.
Industries
Nr. of Employees
medium (51-250)
Biodesix
Broomfield, Colorado, United States, North America
Products
Blood-based lung nodule risk assessment tests (proteomic classifier)
Blood-based proteomic tests intended to classify the malignancy risk of pulmonary nodules and support clinical decision making around surveillance versus invasive procedures.
Blood-based tumor mutation testing (targeted genomic test)
Targeted blood-based genomic tests to detect actionable tumor mutations to inform targeted therapy eligibility and clinical trial enrollment for non-small cell lung cancer.
Host immune-response classifier (prognostic/predictive immune profiling test)
A blood-based host immune classifier that provides predictive and prognostic information to inform immunotherapy and combination treatment strategies across stages of disease.
Blood-based lung nodule risk assessment tests (proteomic classifier)
Blood-based proteomic tests intended to classify the malignancy risk of pulmonary nodules and support clinical decision making around surveillance versus invasive procedures.
Blood-based tumor mutation testing (targeted genomic test)
Targeted blood-based genomic tests to detect actionable tumor mutations to inform targeted therapy eligibility and clinical trial enrollment for non-small cell lung cancer.
Host immune-response classifier (prognostic/predictive immune profiling test)
A blood-based host immune classifier that provides predictive and prognostic information to inform immunotherapy and combination treatment strategies across stages of disease.
Services
Diagnostic development services (end-to-end)
End-to-end services covering translational research, biomarker discovery, assay design, analytical and clinical validation, and commercialization support for diagnostic tests.
Biopharma laboratory services (cfDNA/ctDNA monitoring, protein profiling)
Laboratory testing and longitudinal monitoring services for clinical development including cfDNA/cfRNA testing, ddPCR, NGS profiling, targeted and untargeted proteomics, and sample logistics.
Life sciences development services (translational research and assay validation)
Support for translational research projects including biomarker discovery, assay validation, clinical sample testing, and operational support for research studies.
Sample logistics and kit manufacturing
Design, manufacture, and supply of specimen collection kits, plus tracking, returns logistics, and chain-of-custody management to support clinical trials and diagnostic services.
Diagnostic development services (end-to-end)
End-to-end services covering translational research, biomarker discovery, assay design, analytical and clinical validation, and commercialization support for diagnostic tests.
Biopharma laboratory services (cfDNA/ctDNA monitoring, protein profiling)
Laboratory testing and longitudinal monitoring services for clinical development including cfDNA/cfRNA testing, ddPCR, NGS profiling, targeted and untargeted proteomics, and sample logistics.
Life sciences development services (translational research and assay validation)
Support for translational research projects including biomarker discovery, assay validation, clinical sample testing, and operational support for research studies.
Sample logistics and kit manufacturing
Design, manufacture, and supply of specimen collection kits, plus tracking, returns logistics, and chain-of-custody management to support clinical trials and diagnostic services.
Expertise Areas
- Diagnostic assay development
- Liquid biopsy and ctDNA/cfRNA testing
- Proteomics and biomarker discovery
- Clinical trial sample testing and support
Key Technologies
- Droplet digital PCR (ddPCR)
- Next-generation sequencing (NGS)
- Liquid chromatography–tandem mass spectrometry (LC-MS/MS)
- MALDI-TOF mass spectrometry